{{Rsnum
|rsid=948962
|Gene=MYO7A
|Chromosome=11
|position=77208433
|Orientation=minus
|ReferenceAllele=C
|MissenseAllele=A
|GMAF=0.4775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=MYO7A
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 26.5 | 44.2 | 29.2
| HCB | 43.8 | 40.9 | 15.3
| JPT | 49.6 | 42.5 | 8.0
| YRI | 6.1 | 39.5 | 54.4
| ASW | 8.8 | 38.6 | 52.6
| CHB | 43.8 | 40.9 | 15.3
| CHD | 37.0 | 43.5 | 19.4
| GIH | 37.6 | 50.5 | 11.9
| LWK | 3.6 | 31.8 | 64.5
| MEX | 12.1 | 53.4 | 34.5
| MKK | 9.0 | 43.6 | 47.4
| TSI | 22.5 | 51.0 | 26.5
| HapMapRevision=28
}}

{{Venter SNP
|rsid=948962
|allele=A
|frequency=0.383
|uid=1103649728770
|type=heterozygous_SNP
|hugo=MYO7A
|ensembl gene=ENSG00000137474
|ensembl transcript=ENST00000358342
|sift=TOLERATED
|disease=Defects in MYO7A are the cause of autosomal dominant nonsyndromic sensorineural deafness 11 (DFNA11) (MIM:601317). DFNA11 is a form of nonsyndromic sensorineural deafness with onset after complete speech acquisition and subsequent gradual progression.
}}

{{PMID Auto
|PMID=18776599
|Title=Susceptibility genes for gentamicin-induced vestibular dysfunction.
|OA=1
}}

{{GET Evidence
|gene=MYO7A
|aa_change=Leu1954Ile
|aa_change_short=L1954I
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs948962
|overall_frequency_n=5659
|overall_frequency_d=10314
|overall_frequency=0.548672
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=67
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=-2
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}